IPXL Financial Facts
Patent litigation: 3.28MTotal revenues: 227.91M
See Full Income Statement
Prepaid expenses and other current assets: 61.32M
Additional paid-in capital: 531.3M
See Full Balance Sheet
Impax Laboratories Inc. (IPXL) Earnings
|
Expand Research on IPXL
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +7.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/9/17 |  |
Q217 | $0.18 | $0.14 | +$0.04 | $202.1M | $195.62M | = |  | | Details |
11/9/15  |
|
Q315 | $0.40 | $0.39 | +$0.01 | $221.1M | $214.69M | N/A | | | Details |
| 7/31/12 |
|
Q212 | $0.60 | $0.44 | +$0.16 | $166.5M | $162.03M | N/A | | | Details |
| 5/10/17 | |
Q117 | $0.11 | $0.13 | -$0.02 | $184.4M | $191.25M | = | | | Details |
| 11/4/13 |
|
Q313 | $0.00 | -$0.07 | +$0.07 | $132.6M | $111.83M | N/A | | | Details |
| 5/3/11 |
|
Q111 | $0.24 | $0.15 | +$0.09 | $108.7M | $100.21M | N/A | | | Details |
| 2/25/13 |
|
Q412 | $0.23 | $0.19 | +$0.04 | $141.1M | $127.03M | N/A | | | Details |
| 11/4/14 |
|
Q314 | $0.33 | $0.31 | +$0.02 | $158M | $148.36M | N/A | | | Details |
